华正新材：10月23日召开董事会会议

Group 1 - The core point of the article is that Huazheng New Materials (SH 603186) announced the results of its board meeting held on October 23, 2025, where the proposal to elect Mr. Xu Liang as a non-independent director was reviewed [1] - For the fiscal year 2024, the revenue composition of Huazheng New Materials is reported to be 97.76% from composite materials and 2.24% from other businesses [1] - As of the report, Huazheng New Materials has a market capitalization of 6.6 billion yuan [1] Group 2 - The article also highlights that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year, indicating a hot secondary market in biomedicine [1] - A conversation with Lu Gang, a partner at Chuangdong Investment, reveals that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]